{"id":292,"date":"2026-08-27T05:01:58","date_gmt":"2026-08-27T05:01:58","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/dental-practice-value-factors-2026\/"},"modified":"2026-08-27T05:01:58","modified_gmt":"2026-08-27T05:01:58","slug":"dental-practice-value-factors-2026","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dental-practice-value-factors-2026\/","title":{"rendered":"What Factors Determine the Value of a Dental Practice?"},"content":{"rendered":"<h2 id=\"key-takeaways\">Key Takeaways<\/h2>\n<ul>\n<li>Normalized EBITDA multiplied by a market multiple can be the most precise valuation framework for dental practices in 2026, and often replaces the traditional collections-based rule of thumb.<\/li>\n<li>Buyer type can dramatically impact realized value. Institutional and private-equity buyers often pay 5\u201311x EBITDA, while doctor-to-doctor transactions typically use collections-based pricing that can undervalue profitable practices.<\/li>\n<li>Key value drivers include active patient count, dentist dependence, lease terms, payer mix, and equipment condition. Each factor can compress or support the final multiple depending on how it is managed before going to market.<\/li>\n<li>McLerran &amp; Associates\u2019 sell-side process creates competitive tension through a structured bid process, typically generating around 10 offers and delivering approximately 30% higher valuations than owners achieve selling independently.<\/li>\n<li>Owners ready to understand their practice\u2019s true market position can <a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">request your complimentary practice valuation<\/a> and receive a diligence-grade analysis with a side-by-side comparison of private-buyer versus DSO outcomes.<\/li>\n<\/ul>\n<h2>Valuation Methods Used in 2026 Dental Practice Sales<\/h2>\n<p>Two primary frameworks are used to value U.S. dental practices in 2026, and each tends to align with a different buyer type. Knowing how both work, and which buyers use which method, helps you keep control of your outcome. McLerran &amp; Associates has completed roughly 2,000 practice sales representing approximately $2 billion in closed transaction volume, which provides a data-rich view of how these methods play out across buyer types.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<table>\n<thead>\n<tr>\n<th>Method<\/th>\n<th>How It Works<\/th>\n<th>Typical Buyer<\/th>\n<th>Key Limitation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Collections-Based (% of Revenue)<\/td>\n<td>General dental practices in private transactions can be valued based on a percentage of annual gross collections.<\/td>\n<td>Individual doctor buyers; SBA-financed transitions<\/td>\n<td>Ignores profitability, so two practices with identical collections can have very different values depending on overhead and owner dependence.<\/td>\n<\/tr>\n<tr>\n<td>SDE-Based (Seller&#8217;s Discretionary Earnings)<\/td>\n<td>Net income plus owner salary, owner perks, and documented add-backs. Private buyers pay multiples of SDE for smaller practices.<\/td>\n<td>Individual doctor buyers; smaller practice transitions<\/td>\n<td>Caps out at what a single buyer can finance and does not capture institutional demand.<\/td>\n<\/tr>\n<tr>\n<td>EBITDA-Based (Normalized Multiple)<\/td>\n<td>Adjusted EBITDA multiplied by a market multiple. FOCUS Investment Banking (Dec 2025) reports general dentistry add-on acquisitions at 5\u20138x EBITDA and platform transactions at 9\u201311x EBITDA, with typical revenue multiples of 1.0\u20131.8x.<\/td>\n<td>Institutional buyers; private equity-backed platforms; regional groups<\/td>\n<td>Requires diligence-grade add-back analysis. A weak EBITDA build often gets renegotiated down in due diligence.<\/td>\n<\/tr>\n<tr>\n<td>Platform \/ Enterprise Value<\/td>\n<td>Applied to multi-location groups with $3M+ EBITDA. <a href=\"https:\/\/thesorso.com\/answers\/dental-practice-ebitda-multiple\" target=\"_blank\" rel=\"noindex nofollow\">Emerging platforms ($3\u20135M EBITDA) can reach 9\u201311x, and $5M+ EBITDA platform-grade groups can reach 10\u201312x or more<\/a>, per FOCUS Investment Banking Dec 2025 and McLerran &amp; Associates Jul 2026.<\/td>\n<td>Private equity-backed platforms; strategic acquirers<\/td>\n<td>Requires associate depth, multi-site infrastructure, and clean reporting to qualify.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The table illustrates why the valuation method matters. Institutional buyers can often pay a premium over private-buyer valuations on the same practice because they use EBITDA-based pricing instead of collections-based pricing. That gap is where sell-side representation can earn its value.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">See how your practice values under each method<\/a> with a confidential, diligence-grade review of your numbers.<\/p>\n<h2>EBITDA Multiples and the Role of Add-Backs<\/h2>\n<h3>How many times EBITDA is a dental practice worth?<\/h3>\n<p>The EBITDA multiple a practice can achieve depends on its scale, profitability, buyer type, and operational profile. As shown in the valuation methods table, U.S. dental practices often sell for approximately 5x\u201311x adjusted EBITDA in 2026, with the multiple shaped heavily by practice scale and buyer type.<\/p>\n<p>FOCUS Investment Banking (Dec 2025) publishes a four-rung EBITDA ladder: practices under $1M adjusted EBITDA at 5\u20137x (small institutional tuck-ins or individual buyers), $1M\u2013$3M at 7\u20139x (regional institutional add-ons), $3M\u2013$5M at 9\u201311x (emerging platforms), and $5M+ at 11x or higher in select cases. A practice with $800K adjusted EBITDA values at roughly $4.0M\u2013$5.6M on that ladder. The same practice grown to $3.5M adjusted EBITDA values at $31.5M\u2013$38.5M.<\/p>\n<p>McLerran &amp; Associates builds the EBITDA analysis before the practice goes to market. This diligence-grade work is designed to hold up when buyers scrutinize it and to reduce the risk that the agreed value gets renegotiated down later.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<h3>What is the typical rule of thumb for valuing a dental practice?<\/h3>\n<p>The collections-based rule of thumb, which prices a practice at a percentage of annual revenue, remains common in doctor-to-doctor transactions. That benchmark can be a useful starting point, yet it can significantly understate value for a profitable practice entering a competitive DSO process.<\/p>\n<p>The more precise framework is: <strong>Practice Value = Normalized EBITDA \u00d7 Market Multiple<\/strong>. A $100K change in normalized EBITDA from missed add-backs or misclassified expenses can reduce a dental practice&#8217;s sale valuation by $600K\u2013$800K at typical 6x\u20138x multiples. McLerran\u2019s CPA-led add-back analysis, which unpacks every discretionary, personal, and non-recurring expense, forms the foundation of each engagement.<\/p>\n<p>To make that analysis concrete, owners can review several common add-back categories that often increase normalized EBITDA.<\/p>\n<ul>\n<li>Above-market owner compensation, meaning the excess over what a replacement associate would cost at market rate.<\/li>\n<li>Personal or discretionary expenses run through the business, such as vehicle costs or club memberships.<\/li>\n<li>One-time legal or consulting fees that will not recur under normal operations.<\/li>\n<li>Family member payroll above documented market compensation levels.<\/li>\n<li>Depreciation and amortization, which are non-cash charges added back to reflect actual cash generation.<\/li>\n<\/ul>\n<p>Normalized EBITDA with legitimate add-backs can provide a meaningful lift to the earnings figure in dental practice acquisitions. Every add-back must be documented and defensible, since aggressive or unsupported adjustments are routinely stripped out during buyer due diligence.<\/p>\n<h2>Patient Base, Dentist Dependence, and Lease Terms<\/h2>\n<h3>How does active patient count affect valuation?<\/h3>\n<p>Active patient count, typically defined as patients seen within the prior 18\u201324 months, is a primary value driver because it directly supports recurring revenue projections for both institutional and individual buyers. Institutional buyers generally target practices with a significant number of active patients, and the platform-eligible threshold is often 2,500 or more active patients paired with 5 or more operatories.<\/p>\n<p>Practices that allow active patient count to decline before a sale can experience multiple compression. Buyers also evaluate patient quality beyond raw headcount. Recall compliance, retention rates, new-patient additions per month, and average production per active patient all influence how durable the revenue story appears.<\/p>\n<p>McLerran&#8217;s competitive process, which typically generates around 10 offers over a 45\u201360-day bid window, creates the tension that can convert a strong patient base into a higher realized price. A structured multiple-buyer solicitation process often leads to higher final sale values than initial unsolicited offers.<\/p>\n<h3>What impact does dentist dependence have on goodwill?<\/h3>\n<p>Dentist dependence, meaning the share of total clinical production performed by the selling owner, is one of the most consequential risk factors in any dental practice valuation. Practices where the owner-doctor produces 90% or more of clinical revenue can face a valuation reduction because institutional acquirers cannot underwrite production that exits with the seller.<\/p>\n<p>Buyers model post-sale revenue retention in detail. When the selling dentist generates a high percentage of production with no associate, patient attrition after departure can be significant. Adding an associate who generates 30\u201340% of production reduces transition risk and supports a higher multiple because more EBITDA is considered durable after closing.<\/p>\n<p>Goodwill, which reflects the intangible value of patient relationships, brand, and practice reputation, can account for 60\u201380% of a practice&#8217;s total sale price. High dentist dependence erodes the transferability of that goodwill and compresses both the multiple and the absolute dollar value of the deal. McLerran&#8217;s sell-side process addresses this risk proactively by framing the EBITDA narrative around durable, transferable earnings rather than owner-dependent production.<\/p>\n<h3>How does lease term affect sale price?<\/h3>\n<p>The remaining term of a dental practice&#8217;s property lease is a direct valuation input, not a secondary consideration. A lease expiring in 18 months without renewal options or with above-market rent can directly reduce projected profitability and practice value because buyers model facility costs as part of overhead. A long remaining lease and market-rate rent support a premium valuation, while a short lease, above-market rent, or related-party rent situation often pushes the practice toward a discount until rent is normalized, per Practice Worth observed transaction data.<\/p>\n<p>A clean, assignable lease with favorable terms removes a major deal risk and supports buyer confidence in the durability of the practice&#8217;s cost structure. McLerran identifies lease issues early in the engagement, before they become diligence surprises that erode value or derail a closing.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">See how your lease and patient base affect your valuation<\/a> in a free, confidential analysis.<\/p>\n<h2>How Buyer Type Changes the Multiple<\/h2>\n<p>Buyer type can be one of the largest determinants of realized value for a practice with otherwise identical financial and operational metrics. Institutional buyers can often pay a premium over private-buyer valuations on the same practice because they use EBITDA-based pricing instead of collections-based pricing.<\/p>\n<p>The table below illustrates how the same practice can receive materially different outcomes depending on buyer type. All figures are illustrative ranges drawn from cited market data and should not be interpreted as a guarantee of any specific outcome.<\/p>\n<table>\n<thead>\n<tr>\n<th>Factor<\/th>\n<th>Doctor-to-Doctor Buyer<\/th>\n<th>Institutional \/ Private Equity Buyer<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Valuation method<\/td>\n<td>Collections-based, typically 60\u201385% of trailing 12-month collections<\/td>\n<td>EBITDA-based, often 5\u201311x normalized EBITDA depending on scale and profile<\/td>\n<\/tr>\n<tr>\n<td>Capital source<\/td>\n<td>Individual buyer&#8217;s personal credit, SBA or conventional lending<\/td>\n<td>Corporate-level financing that is not constrained by individual debt service limits<\/td>\n<\/tr>\n<tr>\n<td>Typical cash at close<\/td>\n<td>75\u201385% cash at close, with 10\u201325% seller financing common<\/td>\n<td><a href=\"https:\/\/m.dentalgoodnews.com\/sys-nd\/2888.html\" target=\"_blank\" rel=\"noindex nofollow\">60\u201380% cash at close, with the remainder in joint venture or holding company equity<\/a>, per TUSK Q3 2026<\/td>\n<\/tr>\n<tr>\n<td>Post-close work requirement<\/td>\n<td>Typically 4\u20138 weeks for a walk-away sale<\/td>\n<td>Minimum 3\u20135-year working agreement typical<\/td>\n<\/tr>\n<tr>\n<td>Competitive tension<\/td>\n<td>Limited and constrained by the individual buyer pool and financing<\/td>\n<td>Auction-style process can add 15\u201340% to headline sale price versus single-buyer negotiation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Drawing on that transaction history, McLerran works both pathways in roughly equal measure, which is relatively rare among advisory firms. Clients receive a genuine side-by-side valuation that quantifies their practice&#8217;s worth in both markets before choosing a path. As noted earlier, the firm&#8217;s competitive process has historically delivered a significant valuation premium over unrepresented sales, and McLerran&#8217;s transaction rate of approximately 85\u201390% compares favorably to an industry norm closer to 35\u201340%.<\/p>\n<h2>Find The Right Fit: Transition Risk Checklist<\/h2>\n<p>Price is only one variable that shapes your outcome. Several operational and structural factors can function as diligence red flags that erode value, or as strengths that support a premium, depending on how they are managed before the practice goes to market.<\/p>\n<ul>\n<li><strong>Dentist dependence:<\/strong> Practices where the owner performs a high percentage of production can face valuation discounts due to provider concentration risk. This risk compounds when buyers also see limited associate coverage or weak hygiene support.<\/li>\n<li><strong>Lease expiration:<\/strong> Beyond provider risk, facility uncertainty can also erode value. A short remaining lease term or an unassignable lease introduces facility risk that buyers price into their offers, so resolving lease issues before going to market helps protect value.<\/li>\n<li><strong>Staff turnover:<\/strong> Operational instability can amplify both provider and facility concerns. Buyers apply lower valuation multiples to practices with high turnover, provider gaps, or heavy reliance on temporary labor. Tenured staff who intend to stay through transition reduce buyer risk and support higher multiples.<\/li>\n<li><strong>Payer mix:<\/strong> Heavy Medicaid or HMO payer concentration can compress EBITDA multiples as buyers model reimbursement rate risk and re-credentialing complexity. Fee-for-service revenue above 60% of collections tends to support full or above-market multiples.<\/li>\n<li><strong>Equipment condition:<\/strong> Older or poorly maintained equipment can lower a practice&#8217;s sale value because buyers must reserve cash for replacement or upgrades after closing. Modern digital imaging, CBCT, and CAD\/CAM technology reduce post-purchase capital expenditure needs and support higher multiples.<\/li>\n<li><strong>Collections trend:<\/strong> Practices with growing revenues often receive valuation premiums, stable-growth practices are valued in the mid-range, and practices with negative growth are valued at a discount.<\/li>\n<\/ul>\n<p>McLerran identifies these risk factors at the outset of every engagement, before they become diligence surprises, and works with owners to mitigate them or frame them accurately in the EBITDA narrative.<\/p>\n<h2>The McLerran Four-Stage Process<\/h2>\n<p>McLerran &amp; Associates structures every engagement around four stages that help convert practice value into realized proceeds.<\/p>\n<ol>\n<li><strong>Valuation &amp; Strategy:<\/strong> A CPA-led EBITDA analysis and side-by-side valuation that quantifies the practice&#8217;s worth in both the private-buyer and DSO markets before any path is chosen.<\/li>\n<li><strong>Competitive Marketing:<\/strong> A structured, auction-like bid process among a vetted pool of well-qualified buyers, typically generating around 10 offers over 45\u201360 days. Competition tends to push price up and terms in the seller&#8217;s favor.<\/li>\n<li><strong>Buyer Selection:<\/strong> The highest bidder is not always the right buyer. McLerran vets buyers for financial strength, post-close environment, and alignment with the seller&#8217;s goals for patients and staff.<\/li>\n<li><strong>Deal Execution:<\/strong> Quality-of-earnings defense through diligence, LOI negotiation on all terms (cash, equity, earnout structure), and hands-on management through closing, so the agreed value is more likely to hold and the deal is less likely to get re-traded.<\/li>\n<\/ol>\n<p>Owners who sell without representation often negotiate from a significant information disadvantage. A practice owner sells once, while a DSO negotiates every week. McLerran helps level that table.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Start your confidential valuation process<\/a> or join the <strong>McLerran M&amp;A Summit on October 29\u201330, 2026<\/strong>, a dental-only event built for owners who have not decided yet. Attendees earn 4 CE credits and receive a complimentary practice valuation (a $2,500 value).<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the typical rule of thumb for valuing a dental practice in 2026?<\/h3>\n<p>The traditional rule of thumb prices a general dental practice at 60\u201385% of annual gross collections in a doctor-to-doctor transaction. That benchmark remains useful as a quick reference, yet it can significantly understate value for a profitable practice entering a competitive DSO process. The more precise and widely used framework in 2026 is normalized EBITDA multiplied by a market multiple. EBITDA, which stands for earnings before interest, taxes, depreciation, and amortization, is adjusted to remove owner-specific expenses and non-recurring items, producing a figure that reflects what the practice might earn under new ownership. That adjusted number is then multiplied by a multiple that reflects the practice&#8217;s scale, buyer type, and risk profile. Two practices with identical collections can receive materially different valuations depending on their profitability, payer mix, provider structure, and lease terms. A diligence-grade EBITDA analysis, rather than a collections percentage, often forms the foundation of a defensible asking price.<\/p>\n<h3>How does active patient count affect dental practice valuation?<\/h3>\n<p>Active patient count, defined as patients seen within the prior 18\u201324 months, is a primary value driver because it supports the recurring revenue story that buyers, particularly DSOs, use to justify their offers. A large, growing, and well-retained patient base signals durable cash flow that can persist after ownership changes. Buyers evaluate not just raw headcount but also recall compliance rates, new-patient additions per month, and average production per active patient.<\/p>\n<p>Practices that allow active patient count to decline in the 12\u201324 months before a sale can experience direct multiple compression. A strong hygiene department generating a meaningful share of total collections, typically 25\u201335% or more, signals a stable, recurring patient base and supports a stronger valuation multiple. Hygiene production above roughly 30% of collections is often associated with premium multiples and stronger DSO offers because it demonstrates that revenue is not solely dependent on the selling dentist&#8217;s chair time.<\/p>\n<h3>What impact does dentist dependence have on goodwill?<\/h3>\n<p>Dentist dependence, the percentage of total clinical production performed by the selling owner, is one of the most direct risk factors in a dental practice valuation. As discussed in the transition risk section, high dentist dependence creates a valuation challenge. Buyers cannot underwrite production that exits with the seller, which can lead to lower multiples and potential valuation reductions of 10\u201320%.<\/p>\n<p>Goodwill, which can represent 60\u201380% of a practice&#8217;s total sale price, is directly tied to the transferability of patient relationships and practice reputation. If those relationships are concentrated in a single departing dentist, goodwill becomes harder to defend. Adding associate coverage before going to market, or demonstrating that a strong hygiene team and systems-driven patient experience reduce personal dependency, can meaningfully improve both the multiple and the absolute dollar value of the deal.<\/p>\n<h3>How does lease term affect the sale price of a dental practice?<\/h3>\n<p>The remaining term of a dental practice&#8217;s property lease is a direct input into valuation, not a secondary detail. Buyers model facility costs as part of overhead, and a lease that is expiring, above-market, or unassignable introduces risk that gets priced into offers. A short lease without renewal options can compress the multiple applied to adjusted EBITDA because buyers cannot underwrite the practice&#8217;s cost structure beyond the lease term.<\/p>\n<p>A clean, assignable lease with a long remaining term and market-rate rent removes a major deal risk and supports buyer confidence. When the practice owner also owns the building, rent must be normalized to market rate in the EBITDA calculation, since below-market related-party rent overstates profitability and will be adjusted during buyer due diligence. Resolving lease issues before going to market, rather than discovering them during diligence, helps protect value and reduces the chance that deals will be renegotiated or delayed at closing.<\/p>\n<h3>Should I sell to a private buyer or a DSO?<\/h3>\n<p>The right path depends on your practice&#8217;s size, profitability, and your personal goals for what comes after the sale. Smaller premier practices, roughly $1M\u2013$1.5M in annual revenue, often fit a doctor-to-doctor transition, where the buyer is another dentist and the seller typically works back 4\u20138 weeks before exiting. Larger practices, particularly those above $1.5M in revenue, attract serious DSO interest and can achieve materially higher valuations through an EBITDA-based competitive process.<\/p>\n<p>Practices in the $1.5M\u2013$3M revenue range can often go either direction, and the right answer depends on a genuine side-by-side comparison of what each path actually nets the owner after taxes, over time, and across deal structures. Because McLerran &amp; Associates works both pathways in roughly equal measure, the firm produces that comparison for every client before recommending a direction, so the decision is made with fuller information rather than a guess.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Learn what drives dental practice value in 2026. McLerran &#038; Associates walks you through EBITDA multiples, patient base, and buyer type. Start today.<\/p>\n","protected":false},"author":1,"featured_media":291,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-292","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=292"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/292\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/291"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}